Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed ...
Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design ...
Sapu Nano and Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) today announced that Vuong Trieu, Chief Executive Officer, will present the Company’s Deciparticle™ nanomedicine platform at ...
The food and beverage industry is increasingly adopting the use of artificial intelligence (AI) in the development and scale ...
Neurizon receives Bellberry HREC approval for phase 1 NUZ-001 oral liquid formulation study: Melbourne, Australia Friday, May 15, 2026, 16:00 Hrs [IST] Neurizon Therapeutics Limit ...
Quotient Sciences has successfully initiated a clinical study evaluating a novel drug product developed using AI ...
Celcuity (CELC) stock: gedatolisib Phase 3 VIKTORIA-1 PFS gains in HR+/HER2- breast cancer, runway to 2027 and valuation ...
Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical ...
As the demand for safer, more effective, and naturally derived cosmetic ingredients continues to expand worldwide, industry observers point to the company’s growing role in supplying standardized and ...
SAN DIEGO, CA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- Which CRO Is Good at Protein Degradation? Key ...
The 2025-2027 approval helps French innovators access Intravacc's vaccine development, analytical development and cGMP manufacturing services French Ministry approval recognizes Intravacc as a private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results